NO20084214L - Middel for hindring/behandling av irritabelt tarmsyndrom - Google Patents

Middel for hindring/behandling av irritabelt tarmsyndrom

Info

Publication number
NO20084214L
NO20084214L NO20084214A NO20084214A NO20084214L NO 20084214 L NO20084214 L NO 20084214L NO 20084214 A NO20084214 A NO 20084214A NO 20084214 A NO20084214 A NO 20084214A NO 20084214 L NO20084214 L NO 20084214L
Authority
NO
Norway
Prior art keywords
optionally substituted
hydrocarbon group
bowel syndrome
irritable bowel
substituted hydrocarbon
Prior art date
Application number
NO20084214A
Other languages
English (en)
Inventor
Nobuhiro Inatomi
Jun Terauchi
Fumihiko Sato
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38522471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084214(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20084214L publication Critical patent/NO20084214L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

Foreliggende oppfinnelsen tilveiebringer et profylaktisk eller terapeutisk middel for irritabelt tarmsyndrom, som innbefatter en forbindelse representert ved formel (I): hvori R1 representerer en eventuelt substituert hydrokarbongruppe etc., R2 representere et hydrogenatom eller en eventuelt substituert hydrokarbongruppe, R3 representerer et hydrogenatom, en eventuelt substituert hydrokarbongruppe etc, X representerer CHR4 NR4, CO, O eller S (hvori R4 representerer et hydrogenatom, en eventuelt substituert hydrokarbongruppe etc.),Y representerer C, CH eller Nrepresenterer en enkelbinding eller dobbelbinding, ring A representerer en eventuelt substituert 5- til 7-leddet oksygeninneholdende heterocyklisk ring, ring B representerer en eventuelt substituert benzenring, og m representerer et heltall på 1 til 4, eller et salt derav.
NO20084214A 2006-03-20 2008-10-08 Middel for hindring/behandling av irritabelt tarmsyndrom NO20084214L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006076532 2006-03-20
PCT/JP2007/055526 WO2007108442A1 (ja) 2006-03-20 2007-03-19 過敏性腸症候群予防・治療薬

Publications (1)

Publication Number Publication Date
NO20084214L true NO20084214L (no) 2008-10-08

Family

ID=38522471

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084214A NO20084214L (no) 2006-03-20 2008-10-08 Middel for hindring/behandling av irritabelt tarmsyndrom

Country Status (19)

Country Link
US (2) US20090048325A1 (no)
EP (1) EP1997488A4 (no)
JP (1) JP5219799B2 (no)
KR (1) KR20080114743A (no)
CN (1) CN101404994A (no)
AR (1) AR059935A1 (no)
AU (1) AU2007228087A1 (no)
BR (1) BRPI0708805A2 (no)
CA (1) CA2644181A1 (no)
CR (1) CR10267A (no)
IL (1) IL193686A0 (no)
MA (1) MA30326B1 (no)
MX (1) MX2008011969A (no)
NO (1) NO20084214L (no)
PE (1) PE20080122A1 (no)
RU (1) RU2008141305A (no)
TW (1) TW200803837A (no)
WO (1) WO2007108442A1 (no)
ZA (1) ZA200807752B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023059546A1 (en) * 2021-10-04 2023-04-13 Psilosterics, Llc Serotonin receptor agonists and methods of making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326192D0 (en) * 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
HU224220B1 (hu) * 1996-03-08 2005-06-28 Takeda Pharmaceutical Company Limited Triciklusos vegyületek, eljárás előállításukra és alkalmazásuk
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
ATE247967T1 (de) * 1998-06-09 2003-09-15 Takeda Chemical Industries Ltd Pharmazeutische kombination mit einem trizyclischen komponent und mindestens einem aus zolpidem, zopiclone und brotizolam, zur behandlung von schlafstörungen
FR2795323B1 (fr) * 1999-06-23 2001-11-16 Adir Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal
JP2002226367A (ja) 2001-02-02 2002-08-14 Fuji Chem Ind Co Ltd 薬物障害の予防または治療剤
US20050203130A1 (en) * 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US20070088079A1 (en) * 2005-09-20 2007-04-19 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for sleep disorder
AR056076A1 (es) * 2005-09-20 2007-09-19 Takeda Pharmaceutical Agente profilactico o terapeutico para el desorden de sueno
US8138174B2 (en) * 2007-01-10 2012-03-20 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition

Also Published As

Publication number Publication date
ZA200807752B (en) 2009-12-30
JP5219799B2 (ja) 2013-06-26
CA2644181A1 (en) 2007-09-27
AU2007228087A1 (en) 2007-09-27
CR10267A (es) 2008-11-18
KR20080114743A (ko) 2008-12-31
JPWO2007108442A1 (ja) 2009-08-06
BRPI0708805A2 (pt) 2011-06-14
EP1997488A4 (en) 2010-04-21
MA30326B1 (fr) 2009-04-01
US20100267821A1 (en) 2010-10-21
US8183285B2 (en) 2012-05-22
MX2008011969A (es) 2008-10-03
US20090048325A1 (en) 2009-02-19
AR059935A1 (es) 2008-05-07
WO2007108442A1 (ja) 2007-09-27
EP1997488A1 (en) 2008-12-03
RU2008141305A (ru) 2010-04-27
TW200803837A (en) 2008-01-16
CN101404994A (zh) 2009-04-08
PE20080122A1 (es) 2008-04-24
IL193686A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
MY144960A (en) Morpholine type cinnamide compound
NO20081217L (no) Nye benzotiazolonderivater
ME00681B (me) Jedinjenje indola
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
NO20062516L (no) Pyridinforbindelser som inhibitorer av dipeptidylreptidase IV
NO20085288L (no) Nye karbonylerte (aza)cykloheksaner som dopamin D3 reseptorligander
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
TW200745034A (en) New compounds
NO20074592L (no) Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
NO20090295L (no) Substituerte heteroarylderivater
NO20065880L (no) 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
NO20083758L (no) Nye terapautiske kombinasjoner for behandling av depresjon
NO20092049L (no) Nye fenylsulfamoylbenzamidderivater som bradykininantagonister
NO20075904L (no) Benzimidazolforbindelser
NO20085107L (no) Spirosykliske nitriler som proteaseinhibitorer
ATE501103T1 (de) Organische verbindungen
NO20071222L (no) Benzamidforbindelser.
TW200616679A (en) Modified-release preparation
DE602005014629D1 (de) Pyrazolphenylderivate als ppar-aktivatoren
NO20084214L (no) Middel for hindring/behandling av irritabelt tarmsyndrom
NO20083753L (no) Nye pyridinylaminoalkylen- og pyridinyloksyalkylen-syklopropanaminer, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende dem
WO2009004164A3 (fr) Derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK1838653T3 (da) Hidtil ukendte trimethylcyclododecatrienderivater, anvendelse deraf og parfumerede produkter, der indeholder dem
NO20083352L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application